Putin discusses impacts of events in Yemen on global economy with Russian Security Council
Putin urges Russia's Internet business to work actively with defense structures
Russia urges Ukraine to lift blockade of Donbas — Russia’s ambassador to OSCE
Motives of pilot for crashing Germanwings plane remain unclear
Finnish owners to re-register Crimean winery under Russian law
Ukraine straying away from European values despite its integration slogans — expertWorld March 27, 21:52
Hong Kong to continue talks with Russia on signing investment protection agreementEconomy March 27, 21:42
Natural gas export growth is possible in 2015 — Energy Minister NovakEconomy March 27, 21:37
Terrorism in Mideast was triggered by rash actions of external players — Russia's UN envoyRussia March 27, 21:30
Russia may weaken restrictions on Japanese fish imports — agricultural watchdogEconomy March 27, 21:20
ExxonMobil ready to continue cooperation with Rosneft — energy ministerEconomy March 27, 20:59
Deal on Iran’s nuclear issue possible if there is political will — Iran's foreign ministerWorld March 27, 20:54
Ukraine's Radical Party proposes criminalizing denial of 'Russia’s military aggression'World March 27, 20:18
Russia to firmly stand for Middle East Christians’ protection -—Russian UN envoyRussia March 27, 19:59
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.